Atlantic Equities Reiterates Overweight on IDEXX Laboratories, Maintains $600 Price Target
Portfolio Pulse from richadhand@benzinga.com
Atlantic Equities analyst Steve Chesney reiterated an Overweight rating on IDEXX Laboratories (NASDAQ:IDXX) and maintained a $600 price target.
June 07, 2023 | 8:30 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
IDEXX Laboratories receives an Overweight rating from Atlantic Equities analyst Steve Chesney, who maintains a $600 price target.
The Overweight rating from Atlantic Equities analyst Steve Chesney indicates a positive outlook for IDEXX Laboratories. The maintained $600 price target suggests that the analyst believes the stock has potential for growth in the short term. This news is likely to have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100